Modular Medical Inc MODD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MODD is a good fit for your portfolio.
News
-
Modular Medical Announces Steve Gemmell as New Vice President of Engineering
-
Registration Is Now Open for Tribe Public's Webinar Event "Revolutionizing Diabetes Care" Featuring Modular Medical CEO on Wednesday, March 6, 2024
-
Modular Medical Announces Closing of $10 Million Public Offering
-
Modular Medical Announces Pricing of $10 Million Public Offering
-
Modular Medical Announces Proposed Public Offering
Trading Information
- Previous Close Price
- $1.60
- Day Range
- $1.61–1.64
- 52-Week Range
- $0.84–2.22
- Bid/Ask
- $1.40 / $1.60
- Market Cap
- $49.89 Mil
- Volume/Avg
- 31,935 / 192,246
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of an insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. The company's product's seeks to serve both the type 1 and the rapidly growing especially in terms of device adoption, type 2 diabetes markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 38
- Website
- https://www.modular-medical.com
Valuation
|
Metric
|
MODD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 8.92 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MODD
|
|---|---|
Quick Ratio | 1.42 |
Current Ratio | 1.63 |
Interest Coverage | — |
Quick Ratio
MODD
Profitability
|
Metric
|
MODD
|
|---|---|
Return on Assets (Normalized) | −159.77% |
Return on Equity (Normalized) | −201.29% |
Return on Invested Capital (Normalized) | −174.07% |
Return on Assets
MODD
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Jtsqfrh | Xnyxwt | $184.2 Bil | |
SYK
| Stryker Corp | Trdxjwmy | Nmdn | $125.1 Bil | |
MDT
| Medtronic PLC | Xtnzfblh | Nhntcj | $108.5 Bil | |
BSX
| Boston Scientific Corp | Tpljrhklg | Nzyryll | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Jsxzdsywj | Yjcqhxr | $51.4 Bil | |
DXCM
| DexCom Inc | Nhgcrywqrt | Mpcv | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Wjlrxhgsc | Jvkgm | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Mnmglbb | Jyqypy | $24.4 Bil | |
ALGN
| Align Technology Inc | Qjngyrnr | Tgzjhc | $21.7 Bil | |
PODD
| Insulet Corp | Xqsdfdcjwy | Fsvhbz | $12.2 Bil |